Who owns OMEGA THERAPEUTICS INC?

Tip: Access positions for across all investors

Analyze quarterly positions in Omega Therapeutics with up to 7 years of data, all consolidated into one spreadsheet

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Top investors of Omega Therapeutics stock

Who bought or sold OMEGA THERAPEUTICS INC this quarter?

Fund or Company Name Shares Held Valued At Change in Shares As Of Actions
Flagship Ventures Management 29M $22M 0% Dec 2024
 View chart
FMR 5.9M $4.4M -2% Dec 2024
 View chart
HarbourVest Partners 3.5M $2.6M 0% Dec 2024
 View chart
State of Wisconsin Investment Board 1.9M $1.4M 0% Dec 2024
 View chart
Siren 1.3M $1.6M 100% Sep 2024
 View chart
Vanguard Group 1.1M $818k -2% Dec 2024
 View chart
Blue Owl Capital Holdings 1.1M $1.3M 0% Sep 2024
 View chart
683 Capital Management 600k $447k 0% Dec 2024
 View chart
Millennium Management 521k $388k -3% Dec 2024
 View chart
72 Investment Holdings 353k $431k 0% Sep 2024
 View chart
BlackRock 272k $203k 0% Dec 2024
 View chart
Geode Capital Management 231k $172k 0% Dec 2024
 View chart
State Treasurer State Of Michigan 224k $167k -29% Dec 2024
 View chart
UBS Group 164k $122k 5378% Dec 2024
 View chart
Woodline Partners 122k $91k 100% Dec 2024
 View chart
Point72 Asset Management 116k $87k 0% Dec 2024
 View chart
State Street Corporation 95k $71k 0% Dec 2024
 View chart
Long Corridor Asset Management 85k $104k 100% Sep 2024
 View chart
Bridgeway Capital Management 64k $48k -46% Dec 2024
 View chart
Rbf Capital 64k $48k 0% Dec 2024
 View chart
Raymond James Financial Services Advisors 60k $73k 56% Sep 2024
 View chart
Green Alpha Advisors 48k $36k -24% Dec 2024
 View chart
Northern Trust 40k $30k 0% Dec 2024
 View chart
Cubist Systematic Strategies 32k $24k 0% Dec 2024
 View chart
Citadel Advisors 30k $23k 135% Dec 2024
 View chart
Raymond James Financial 30k $22k 100% Dec 2024
 View chart
Morgan Stanley 29k $21k -35% Dec 2024
 View chart
Pathstone Holdings 27k $20k -34% Dec 2024
 View chart
Two Sigma Investments 22k $16k -73% Dec 2024
 View chart
Camden Capital 20k $15k 33% Dec 2024
 View chart
Wells Fargo & Company 18k $14k -21% Dec 2024
 View chart
Renaissance Technologies 18k $13k -96% Dec 2024
 View chart
Murphy Pohlad Asset Management 17k $12k 0% Dec 2024
 View chart
Eqis Capital Management 15k $11k 18% Dec 2024
 View chart
Colony 14k $10k 100% Dec 2024
 View chart
Barclays 13k $10k 0% Dec 2024
 View chart
Two Sigma Securities 12k $9.0k 100% Dec 2024
 View chart
Bank of America Corporation 5.1k $3.8k -69% Dec 2024
 View chart
Steward Partners Investment Advisory 5.0k $3.7k 0% Dec 2024
 View chart
Citigroup 2.7k $1.8k 8674% Dec 2024
 View chart
Hm Payson & Co 2.5k $1.9k 100% Dec 2024
 View chart
Principal Securities 1.4k $1.0k 0% Dec 2024
 View chart
AllSquare Wealth Management 1.0k $746.000000 0% Dec 2024
 View chart
Point72 954.00 $711.016200 0% Dec 2024
 View chart
Group One Trading 900.00 $671.040000 -74% Dec 2024
 View chart
Sandy Spring Bank 750.00 $560.025000 0% Dec 2024
 View chart
Jpmorgan Chase & Co 503.00 $374.986500 0% Dec 2024
 View chart
SBI Securities 415.00 $309.009000 100% Dec 2024
 View chart
Simplex Trading 342.00 $0 -77% Dec 2024
 View chart
Tower Research Capital 292.00 $218.007200 -94% Dec 2024
 View chart
Bnp Paribas Arbitrage, Snc 235.00 $175.004500 100% Dec 2024
 View chart
Royal Bank of Canada 67.00 $0 0% Dec 2024
 View chart
Capital A Wealth Management 24.00 $18.000000 100% Dec 2024
 View chart
Huntington National Bank 1.00 $1.000000 0% Dec 2024
 View chart

Who sold out of Omega Therapeutics?

Fund or Company Name Date Sold Shares Held Valued At
Platinum Investment Mangement Sep 2024 346k $423k
XTX Topco Sep 2024 32k $39k
Susquehanna International Sep 2024 20k $24k
Squarepoint Ops Sep 2024 18k $22k
Mirae Asset Global Etfs Holdings Jun 2024 13k $27k
Catalyst Funds Management Pty Jun 2024 6.1k $13k
Harbour Investments Sep 2024 275.00 $335.995000
Advisor Group Holdings Sep 2024 200.00 $244.000000
SRS Capital Advisors Sep 2024 54.00 $65.998800